

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 4.03367039 |
| 2 | central nervous system myelination (GO:0022010) | 4.03367039 |
| 3 | acrosome reaction (GO:0007340) | 3.67994369 |
| 4 | sperm motility (GO:0030317) | 3.52689240 |
| 5 | fatty acid elongation (GO:0030497) | 3.43369798 |
| 6 | synaptic vesicle maturation (GO:0016188) | 3.36559627 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.34985015 |
| 8 | gamma-aminobutyric acid transport (GO:0015812) | 3.31649160 |
| 9 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.14737596 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 3.10772114 |
| 11 | negative regulation of inclusion body assembly (GO:0090084) | 3.07163391 |
| 12 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.06528642 |
| 13 | locomotory exploration behavior (GO:0035641) | 3.06350688 |
| 14 | L-amino acid import (GO:0043092) | 3.04639435 |
| 15 | glutamate secretion (GO:0014047) | 2.96863520 |
| 16 | neuronal action potential propagation (GO:0019227) | 2.95735663 |
| 17 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95283557 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.94824464 |
| 19 | calcium ion-dependent exocytosis (GO:0017156) | 2.94350411 |
| 20 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.91953890 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.89359861 |
| 22 | response to methylmercury (GO:0051597) | 2.88785624 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 2.86408343 |
| 24 | dendrite morphogenesis (GO:0048813) | 2.75323699 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 2.73655578 |
| 26 | L-phenylalanine catabolic process (GO:0006559) | 2.73458426 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.73458426 |
| 28 | vocalization behavior (GO:0071625) | 2.73214171 |
| 29 | ensheathment of neurons (GO:0007272) | 2.69367459 |
| 30 | axon ensheathment (GO:0008366) | 2.69367459 |
| 31 | response to peptidoglycan (GO:0032494) | 2.68988818 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68929388 |
| 33 | myelination (GO:0042552) | 2.68593031 |
| 34 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.68086693 |
| 35 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.68023499 |
| 36 | acrosome assembly (GO:0001675) | 2.63754251 |
| 37 | layer formation in cerebral cortex (GO:0021819) | 2.62944392 |
| 38 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.62918468 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 2.62739215 |
| 40 | multicellular organism reproduction (GO:0032504) | 2.60894903 |
| 41 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.60893809 |
| 42 | response to nerve growth factor (GO:1990089) | 2.60893809 |
| 43 | cell wall macromolecule metabolic process (GO:0044036) | 2.58329803 |
| 44 | cell wall macromolecule catabolic process (GO:0016998) | 2.58329803 |
| 45 | negative regulation of neurotransmitter transport (GO:0051589) | 2.57605225 |
| 46 | dendritic spine morphogenesis (GO:0060997) | 2.57290910 |
| 47 | cellular potassium ion homeostasis (GO:0030007) | 2.56381894 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.55865606 |
| 49 | plasma membrane fusion (GO:0045026) | 2.54086346 |
| 50 | protein localization to synapse (GO:0035418) | 2.53448793 |
| 51 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.51721352 |
| 52 | neurotransmitter secretion (GO:0007269) | 2.51029426 |
| 53 | cerebellar granule cell differentiation (GO:0021707) | 2.47626473 |
| 54 | response to muramyl dipeptide (GO:0032495) | 2.45915904 |
| 55 | glycine transport (GO:0015816) | 2.45148597 |
| 56 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.43740247 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 2.42264184 |
| 58 | positive regulation of p38MAPK cascade (GO:1900745) | 2.41711331 |
| 59 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.41071874 |
| 60 | neuromuscular process controlling posture (GO:0050884) | 2.40391764 |
| 61 | transmission of nerve impulse (GO:0019226) | 2.39880494 |
| 62 | membrane depolarization during action potential (GO:0086010) | 2.39794659 |
| 63 | regulation of fever generation (GO:0031620) | 2.39322182 |
| 64 | mating behavior (GO:0007617) | 2.38755017 |
| 65 | vesicle transport along microtubule (GO:0047496) | 2.38431266 |
| 66 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.38368596 |
| 67 | presynaptic membrane assembly (GO:0097105) | 2.37181199 |
| 68 | glutamate receptor signaling pathway (GO:0007215) | 2.35834971 |
| 69 | sperm capacitation (GO:0048240) | 2.35676485 |
| 70 | neuron recognition (GO:0008038) | 2.34180371 |
| 71 | nerve growth factor signaling pathway (GO:0038180) | 2.33915411 |
| 72 | epithelial cilium movement (GO:0003351) | 2.33797553 |
| 73 | adult walking behavior (GO:0007628) | 2.32230930 |
| 74 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.30893748 |
| 75 | presynaptic membrane organization (GO:0097090) | 2.30875469 |
| 76 | exploration behavior (GO:0035640) | 2.30830676 |
| 77 | reproduction (GO:0000003) | 2.29688059 |
| 78 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.29217556 |
| 79 | negative regulation of type 2 immune response (GO:0002829) | 2.28773473 |
| 80 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.28451003 |
| 81 | proline transport (GO:0015824) | 2.28268212 |
| 82 | regulation of type 2 immune response (GO:0002828) | 2.27928621 |
| 83 | protein localization to endosome (GO:0036010) | 2.27233848 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.26542707 |
| 85 | sodium ion export (GO:0071436) | 2.25956519 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.25689115 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 2.25689115 |
| 88 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.25538205 |
| 89 | organelle transport along microtubule (GO:0072384) | 2.25383619 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 2.25286174 |
| 91 | positive regulation of type 2 immune response (GO:0002830) | 2.24340084 |
| 92 | amino acid import (GO:0043090) | 2.24097223 |
| 93 | germinal center formation (GO:0002467) | 2.23785960 |
| 94 | positive regulation by symbiont of host defense response (GO:0052509) | 2.23701741 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 2.23701741 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.23701741 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.23701741 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.23701741 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 2.23701741 |
| 100 | macroautophagy (GO:0016236) | 2.23204173 |
| 101 | regulation of synapse structural plasticity (GO:0051823) | 2.22899647 |
| 102 | import into cell (GO:0098657) | 2.22469117 |
| 103 | neuron-neuron synaptic transmission (GO:0007270) | 2.21927074 |
| 104 | neurotransmitter transport (GO:0006836) | 2.19854871 |
| 105 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.19684560 |
| 106 | Rap protein signal transduction (GO:0032486) | 2.19636436 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.19042193 |
| 108 | synaptic transmission, glutamatergic (GO:0035249) | 2.18611582 |
| 109 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.17993943 |
| 110 | neuronal ion channel clustering (GO:0045161) | 2.17427069 |
| 111 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.17262208 |
| 112 | cell migration in hindbrain (GO:0021535) | 2.17004882 |
| 113 | neuromuscular process controlling balance (GO:0050885) | 2.16943418 |
| 114 | potassium ion import (GO:0010107) | 2.16854418 |
| 115 | behavioral response to cocaine (GO:0048148) | 2.16744030 |
| 116 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.16076120 |
| 117 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.15206974 |
| 118 | axonemal dynein complex assembly (GO:0070286) | 2.13790230 |
| 119 | neurotransmitter catabolic process (GO:0042135) | 2.13525486 |
| 120 | prepulse inhibition (GO:0060134) | 2.13480934 |
| 121 | activation of protein kinase A activity (GO:0034199) | 2.13177789 |
| 122 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.12193502 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.10934469 |
| 124 | positive regulation of heat generation (GO:0031652) | 2.09905340 |
| 125 | protein targeting to Golgi (GO:0000042) | 2.09020842 |
| 126 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.08119728 |
| 127 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.07989722 |
| 128 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.07846408 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.07639386 |
| 130 | positive regulation of Rap GTPase activity (GO:0032854) | 2.07255270 |
| 131 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.04517570 |
| 132 | cell adhesion mediated by integrin (GO:0033627) | 2.03611364 |
| 133 | response to manganese ion (GO:0010042) | 2.03576834 |
| 134 | regulation of p38MAPK cascade (GO:1900744) | 2.03425145 |
| 135 | detection of external biotic stimulus (GO:0098581) | 2.00855751 |
| 136 | skin morphogenesis (GO:0043589) | 2.00766255 |
| 137 | regulation of ARF protein signal transduction (GO:0032012) | 2.00754550 |
| 138 | positive regulation of macrophage cytokine production (GO:0060907) | 1.99839916 |
| 139 | cellular response to ethanol (GO:0071361) | 1.98307252 |
| 140 | interleukin-6-mediated signaling pathway (GO:0070102) | 1.98147115 |
| 141 | T-helper 1 type immune response (GO:0042088) | 1.97407583 |
| 142 | macrophage activation (GO:0042116) | 1.96918924 |
| 143 | establishment of endothelial barrier (GO:0061028) | 1.96556001 |
| 144 | response to fluid shear stress (GO:0034405) | 1.96121268 |
| 145 | regulation of macrophage cytokine production (GO:0010935) | 1.94282884 |
| 146 | detection of other organism (GO:0098543) | 1.93485812 |
| 147 | regulation of Rap GTPase activity (GO:0032317) | 1.92889536 |
| 148 | response to laminar fluid shear stress (GO:0034616) | 1.92344443 |
| 149 | stress fiber assembly (GO:0043149) | 1.91713907 |
| 150 | cellular response to epinephrine stimulus (GO:0071872) | 1.90957194 |
| 151 | negative regulation of vascular permeability (GO:0043116) | 1.89550718 |
| 152 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.88264192 |
| 153 | endocytic recycling (GO:0032456) | 1.87364574 |
| 154 | virion attachment to host cell (GO:0019062) | 1.87156807 |
| 155 | adhesion of symbiont to host cell (GO:0044650) | 1.87156807 |
| 156 | microglial cell activation (GO:0001774) | 1.86481865 |
| 157 | regulation of interferon-beta biosynthetic process (GO:0045357) | 1.86103331 |
| 158 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 1.86101618 |
| 159 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 1.85363505 |
| 160 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 1.84793405 |
| 161 | hypotonic response (GO:0006971) | 1.82840582 |
| 162 | cellular response to thyroid hormone stimulus (GO:0097067) | 1.81480493 |
| 163 | neuron remodeling (GO:0016322) | 1.81059415 |
| 164 | Notch signaling involved in heart development (GO:0061314) | 1.79996462 |
| 165 | cell communication by electrical coupling (GO:0010644) | 1.79941919 |
| 166 | regulation of heat generation (GO:0031650) | 1.78140527 |
| 167 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.77903152 |
| 168 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.77407357 |
| 169 | positive regulation of receptor recycling (GO:0001921) | 1.76764762 |
| 170 | negative regulation of interleukin-17 production (GO:0032700) | 1.76406797 |
| 171 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 1.75952429 |
| 172 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 1.75867890 |
| 173 | establishment of protein localization to Golgi (GO:0072600) | 1.75614737 |
| 174 | regulation of early endosome to late endosome transport (GO:2000641) | 1.74752475 |
| 175 | cortical actin cytoskeleton organization (GO:0030866) | 1.74489007 |
| 176 | establishment of skin barrier (GO:0061436) | 1.73995690 |
| 177 | early endosome to late endosome transport (GO:0045022) | 1.73508519 |
| 178 | type I interferon signaling pathway (GO:0060337) | 1.73316282 |
| 179 | cellular response to type I interferon (GO:0071357) | 1.73316282 |
| 180 | barbed-end actin filament capping (GO:0051016) | 1.73238296 |
| 181 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 1.72608048 |
| 182 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.71825522 |
| 183 | detection of biotic stimulus (GO:0009595) | 1.71753532 |
| 184 | response to type I interferon (GO:0034340) | 1.71371019 |
| 185 | negative regulation of erythrocyte differentiation (GO:0045647) | 1.71128198 |
| 186 | neutrophil mediated immunity (GO:0002446) | 1.70637496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.40329222 |
| 2 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.82062746 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.52552738 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31007997 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.03388664 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.96483703 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.93042528 |
| 8 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.92999381 |
| 9 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90638455 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86455162 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86188938 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85118704 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81954945 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79692326 |
| 15 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.71674195 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.70329842 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70276651 |
| 18 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.67675000 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66649116 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66208312 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66192560 |
| 22 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65493516 |
| 23 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65493516 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63479391 |
| 25 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60320132 |
| 26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60267920 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59130073 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57465073 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.52091609 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.51188236 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.50542685 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.50327488 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50189223 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49850052 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.48879688 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48838074 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48674384 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44470836 |
| 39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.43991148 |
| 40 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43719289 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40491984 |
| 42 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38078723 |
| 43 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37868635 |
| 44 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37810502 |
| 45 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.37260462 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36917283 |
| 47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.36856908 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35811903 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35624641 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31528780 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31144211 |
| 52 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30366938 |
| 53 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30324378 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29842725 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28834708 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28735590 |
| 57 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27996538 |
| 58 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27183912 |
| 59 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27143897 |
| 60 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.26690149 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.26541153 |
| 62 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26039730 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25964695 |
| 64 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25370377 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.24761892 |
| 66 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23703776 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22569763 |
| 68 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21695596 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21517463 |
| 70 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.20042069 |
| 71 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19271008 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17382171 |
| 73 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.15406925 |
| 74 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13799366 |
| 75 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.12621339 |
| 76 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12360749 |
| 77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11714245 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11665731 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11258254 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.11103120 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.10478232 |
| 82 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09641978 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09099538 |
| 84 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.08926482 |
| 85 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07483802 |
| 86 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07249877 |
| 87 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.07021398 |
| 88 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.06242906 |
| 89 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04968088 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.04556241 |
| 91 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04410604 |
| 92 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04395701 |
| 93 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03927201 |
| 94 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02541111 |
| 95 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02352552 |
| 96 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02218017 |
| 97 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02177611 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.02003371 |
| 99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01315435 |
| 100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00623326 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00069082 |
| 102 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99570399 |
| 103 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99382974 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98707293 |
| 105 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98664554 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98525679 |
| 107 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.98260592 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98095569 |
| 109 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.97914367 |
| 110 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.97486485 |
| 111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97284745 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96393702 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96326352 |
| 114 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96237538 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95778942 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95128741 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95128741 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94521883 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94411534 |
| 120 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93494007 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92845605 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92743583 |
| 123 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92380124 |
| 124 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.92346654 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.92118842 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91560454 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91346829 |
| 128 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91325437 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91198962 |
| 130 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91017395 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90416878 |
| 132 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90394622 |
| 133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90394622 |
| 134 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89755118 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89366597 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89356169 |
| 137 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88413918 |
| 138 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.88042880 |
| 139 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87984235 |
| 140 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87825136 |
| 141 | TBL1_22424771_ChIP-Seq_293T_Human | 0.87460264 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.87359644 |
| 143 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87112081 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.87094124 |
| 145 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86821611 |
| 146 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86571783 |
| 147 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86097745 |
| 148 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.86040208 |
| 149 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85814204 |
| 150 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85440441 |
| 151 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84744974 |
| 152 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.84583413 |
| 153 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83882392 |
| 154 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83152716 |
| 155 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83100139 |
| 156 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82894957 |
| 157 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82894957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 4.07726507 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.95310814 |
| 3 | MP0003303_peritoneal_inflammation | 3.67987614 |
| 4 | MP0004270_analgesia | 3.44711044 |
| 5 | MP0003880_abnormal_central_pattern | 2.98329290 |
| 6 | MP0004510_myositis | 2.92715219 |
| 7 | MP0009046_muscle_twitch | 2.79496898 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.71492654 |
| 9 | MP0003329_amyloid_beta_deposits | 2.66533154 |
| 10 | MP0000920_abnormal_myelination | 2.62655898 |
| 11 | MP0003724_increased_susceptibility_to | 2.51536201 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.50285743 |
| 13 | MP0003690_abnormal_glial_cell | 2.45366138 |
| 14 | MP0002064_seizures | 2.41201296 |
| 15 | MP0002139_abnormal_hepatobiliary_system | 2.30607948 |
| 16 | MP0009745_abnormal_behavioral_response | 2.28475804 |
| 17 | MP0001486_abnormal_startle_reflex | 2.27347134 |
| 18 | MP0006082_CNS_inflammation | 2.26914719 |
| 19 | MP0003091_abnormal_cell_migration | 2.24673041 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.15102024 |
| 21 | MP0005275_abnormal_skin_tensile | 2.13137736 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.12222940 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.08261396 |
| 24 | MP0002272_abnormal_nervous_system | 2.06106551 |
| 25 | MP0005423_abnormal_somatic_nervous | 2.04148333 |
| 26 | MP0005360_urolithiasis | 2.01670111 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.99238561 |
| 28 | MP0002734_abnormal_mechanical_nocicepti | 1.98264120 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.97430276 |
| 30 | MP0005085_abnormal_gallbladder_physiolo | 1.94724993 |
| 31 | MP0003279_aneurysm | 1.90448627 |
| 32 | MP0002822_catalepsy | 1.88515538 |
| 33 | MP0000604_amyloidosis | 1.87713156 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.85310608 |
| 35 | MP0008004_abnormal_stomach_pH | 1.85067435 |
| 36 | MP0001958_emphysema | 1.77464432 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.77257173 |
| 38 | MP0004885_abnormal_endolymph | 1.76704573 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.72640839 |
| 40 | MP0003436_decreased_susceptibility_to | 1.71343491 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.71240908 |
| 42 | MP0000778_abnormal_nervous_system | 1.67919965 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.66470002 |
| 44 | MP0004947_skin_inflammation | 1.62190953 |
| 45 | MP0005365_abnormal_bile_salt | 1.61431061 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.61242351 |
| 47 | MP0001542_abnormal_bone_strength | 1.59603724 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.59214691 |
| 49 | MP0000015_abnormal_ear_pigmentation | 1.58961753 |
| 50 | MP0003191_abnormal_cellular_cholesterol | 1.58545715 |
| 51 | MP0004742_abnormal_vestibular_system | 1.57834362 |
| 52 | MP0005171_absent_coat_pigmentation | 1.56334162 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.52496306 |
| 54 | MP0003633_abnormal_nervous_system | 1.50657621 |
| 55 | MP0002736_abnormal_nociception_after | 1.50409155 |
| 56 | MP0003634_abnormal_glial_cell | 1.50154882 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.48526919 |
| 58 | MP0003828_pulmonary_edema | 1.44836755 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.43272666 |
| 60 | MP0008569_lethality_at_weaning | 1.41929733 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.40893537 |
| 62 | MP0001970_abnormal_pain_threshold | 1.38678489 |
| 63 | MP0003698_abnormal_male_reproductive | 1.36625917 |
| 64 | MP0002419_abnormal_innate_immunity | 1.36244278 |
| 65 | MP0005164_abnormal_response_to | 1.35627587 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.35594557 |
| 67 | MP0004883_abnormal_blood_vessel | 1.33145947 |
| 68 | MP0002796_impaired_skin_barrier | 1.32425005 |
| 69 | MP0003631_nervous_system_phenotype | 1.30740930 |
| 70 | MP0006054_spinal_hemorrhage | 1.30510936 |
| 71 | MP0003950_abnormal_plasma_membrane | 1.30314059 |
| 72 | MP0002229_neurodegeneration | 1.28584129 |
| 73 | MP0000955_abnormal_spinal_cord | 1.26434596 |
| 74 | MP0005386_behavior/neurological_phenoty | 1.26361891 |
| 75 | MP0004924_abnormal_behavior | 1.26361891 |
| 76 | MP0000579_abnormal_nail_morphology | 1.26295079 |
| 77 | MP0005595_abnormal_vascular_smooth | 1.26230073 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.23000477 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.20906534 |
| 80 | MP0004142_abnormal_muscle_tone | 1.19012694 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.18676701 |
| 82 | MP0004484_altered_response_of | 1.17583430 |
| 83 | MP0009785_altered_susceptibility_to | 1.16022482 |
| 84 | MP0001984_abnormal_olfaction | 1.15791503 |
| 85 | MP0003045_fibrosis | 1.15401989 |
| 86 | MP0003632_abnormal_nervous_system | 1.14497813 |
| 87 | MP0003566_abnormal_cell_adhesion | 1.14262137 |
| 88 | MP0002066_abnormal_motor_capabilities/c | 1.13344044 |
| 89 | MP0004858_abnormal_nervous_system | 1.12432288 |
| 90 | MP0002882_abnormal_neuron_morphology | 1.12085767 |
| 91 | MP0000343_altered_response_to | 1.11917634 |
| 92 | MP0005451_abnormal_body_composition | 1.10563138 |
| 93 | MP0009764_decreased_sensitivity_to | 1.10104632 |
| 94 | MP0004381_abnormal_hair_follicle | 1.10091668 |
| 95 | MP0005166_decreased_susceptibility_to | 1.09728559 |
| 96 | MP0010678_abnormal_skin_adnexa | 1.08563164 |
| 97 | MP0005257_abnormal_intraocular_pressure | 1.06686245 |
| 98 | MP0001851_eye_inflammation | 1.03609689 |
| 99 | MP0002148_abnormal_hypersensitivity_rea | 1.03449569 |
| 100 | MP0002118_abnormal_lipid_homeostasis | 1.02985487 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 1.02711293 |
| 102 | MP0003195_calcinosis | 1.02346490 |
| 103 | MP0005000_abnormal_immune_tolerance | 1.02020348 |
| 104 | MP0002557_abnormal_social/conspecific_i | 1.01316777 |
| 105 | MP0005174_abnormal_tail_pigmentation | 1.00894293 |
| 106 | MP0005387_immune_system_phenotype | 1.00121479 |
| 107 | MP0001790_abnormal_immune_system | 1.00121479 |
| 108 | MP0002184_abnormal_innervation | 1.00052731 |
| 109 | MP0010329_abnormal_lipoprotein_level | 0.99099137 |
| 110 | MP0006276_abnormal_autonomic_nervous | 0.98538223 |
| 111 | MP0000371_diluted_coat_color | 0.97668062 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.97657411 |
| 113 | MP0003252_abnormal_bile_duct | 0.97297617 |
| 114 | MP0005083_abnormal_biliary_tract | 0.96473132 |
| 115 | MP0005551_abnormal_eye_electrophysiolog | 0.95309887 |
| 116 | MP0004130_abnormal_muscle_cell | 0.94768177 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.93657321 |
| 118 | MP0000647_abnormal_sebaceous_gland | 0.93248433 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.91110336 |
| 120 | MP0000751_myopathy | 0.90892877 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.90870391 |
| 122 | MP0000767_abnormal_smooth_muscle | 0.90034307 |
| 123 | MP0005025_abnormal_response_to | 0.89748606 |
| 124 | MP0002090_abnormal_vision | 0.89535420 |
| 125 | MP0001905_abnormal_dopamine_level | 0.89461445 |
| 126 | MP0005535_abnormal_body_temperature | 0.89353724 |
| 127 | MP0001835_abnormal_antigen_presentation | 0.89143969 |
| 128 | MP0009840_abnormal_foam_cell | 0.87093095 |
| 129 | MP0004043_abnormal_pH_regulation | 0.86402114 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.86360595 |
| 131 | MP0005023_abnormal_wound_healing | 0.86297567 |
| 132 | MP0001853_heart_inflammation | 0.86080747 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.85895959 |
| 134 | MP0008874_decreased_physiological_sensi | 0.85713233 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.85069669 |
| 136 | MP0001299_abnormal_eye_distance/ | 0.84943979 |
| 137 | MP0005646_abnormal_pituitary_gland | 0.84928811 |
| 138 | MP0001529_abnormal_vocalization | 0.84782456 |
| 139 | MP0001177_atelectasis | 0.84421820 |
| 140 | MP0003448_altered_tumor_morphology | 0.84045838 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.83922234 |
| 142 | MP0002909_abnormal_adrenal_gland | 0.83247680 |
| 143 | MP0004085_abnormal_heartbeat | 0.80897492 |
| 144 | MP0003879_abnormal_hair_cell | 0.78899325 |
| 145 | MP0009384_cardiac_valve_regurgitation | 0.78183567 |
| 146 | MP0000747_muscle_weakness | 0.77931245 |
| 147 | MP0005409_darkened_coat_color | 0.77752534 |
| 148 | MP0002152_abnormal_brain_morphology | 0.76223218 |
| 149 | MP0010234_abnormal_vibrissa_follicle | 0.76211388 |
| 150 | MP0005332_abnormal_amino_acid | 0.75798947 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.75397903 |
| 152 | MP0005388_respiratory_system_phenotype | 0.74521959 |
| 153 | MP0002133_abnormal_respiratory_system | 0.74521959 |
| 154 | MP0005390_skeleton_phenotype | 0.72149646 |
| 155 | MP0000249_abnormal_blood_vessel | 0.71308221 |
| 156 | MP0002723_abnormal_immune_serum | 0.71272261 |
| 157 | MP0004145_abnormal_muscle_electrophysio | 0.71013312 |
| 158 | MP0005076_abnormal_cell_differentiation | 0.70724399 |
| 159 | MP0000383_abnormal_hair_follicle | 0.69402678 |
| 160 | MP0001666_abnormal_nutrient_absorption | 0.69054057 |
| 161 | MP0008260_abnormal_autophagy | 0.69002730 |
| 162 | MP0001929_abnormal_gametogenesis | 0.68957526 |
| 163 | MP0003075_altered_response_to | 0.68763929 |
| 164 | MP0001963_abnormal_hearing_physiology | 0.68366390 |
| 165 | MP0004036_abnormal_muscle_relaxation | 0.67212464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 4.87112646 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 4.52617780 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.52617780 |
| 4 | Myokymia (HP:0002411) | 4.17526124 |
| 5 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.05108785 |
| 6 | Cerebral inclusion bodies (HP:0100314) | 3.94752067 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.78742290 |
| 8 | Focal motor seizures (HP:0011153) | 3.71657943 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 3.55678630 |
| 10 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.45205332 |
| 11 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.45205332 |
| 12 | Termporal pattern (HP:0011008) | 3.42560735 |
| 13 | Insidious onset (HP:0003587) | 3.42560735 |
| 14 | Action tremor (HP:0002345) | 3.41572728 |
| 15 | Focal seizures (HP:0007359) | 3.37105169 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.21911831 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.21911831 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.21911831 |
| 19 | Intention tremor (HP:0002080) | 3.18516190 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.16319597 |
| 21 | Onion bulb formation (HP:0003383) | 3.04115566 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.03658221 |
| 23 | Spastic tetraparesis (HP:0001285) | 2.95331837 |
| 24 | Ankle clonus (HP:0011448) | 2.90336747 |
| 25 | Spastic gait (HP:0002064) | 2.81741362 |
| 26 | Dysmetria (HP:0001310) | 2.76974807 |
| 27 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.76580470 |
| 28 | Peripheral hypomyelination (HP:0007182) | 2.72311772 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 2.70063791 |
| 30 | Disinhibition (HP:0000734) | 2.68792526 |
| 31 | Hyperventilation (HP:0002883) | 2.64990530 |
| 32 | Sensory axonal neuropathy (HP:0003390) | 2.64340546 |
| 33 | Atonic seizures (HP:0010819) | 2.63960072 |
| 34 | Optic neuritis (HP:0100653) | 2.57904903 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 2.57904903 |
| 36 | Orchitis (HP:0100796) | 2.53655150 |
| 37 | Arterial tortuosity (HP:0005116) | 2.49196717 |
| 38 | Vascular tortuosity (HP:0004948) | 2.48075267 |
| 39 | Ulnar claw (HP:0001178) | 2.47400616 |
| 40 | Mutism (HP:0002300) | 2.46401026 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.45178808 |
| 42 | Tetraparesis (HP:0002273) | 2.44430966 |
| 43 | Postural instability (HP:0002172) | 2.44302385 |
| 44 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.43829307 |
| 45 | Epileptic encephalopathy (HP:0200134) | 2.43118692 |
| 46 | Neuronal loss in central nervous system (HP:0002529) | 2.40768472 |
| 47 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.38836669 |
| 48 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.38836669 |
| 49 | Dysdiadochokinesis (HP:0002075) | 2.38292558 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.37181892 |
| 51 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.34745688 |
| 52 | Complement deficiency (HP:0004431) | 2.33613787 |
| 53 | Scanning speech (HP:0002168) | 2.31719883 |
| 54 | Progressive inability to walk (HP:0002505) | 2.31588372 |
| 55 | Generalized tonic-clonic seizures (HP:0002069) | 2.30795241 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.30211771 |
| 57 | Hyperlipoproteinemia (HP:0010980) | 2.29938046 |
| 58 | Pheochromocytoma (HP:0002666) | 2.29106380 |
| 59 | Lower limb muscle weakness (HP:0007340) | 2.27274405 |
| 60 | Xanthomatosis (HP:0000991) | 2.27265169 |
| 61 | Nuclear cataract (HP:0100018) | 2.26937173 |
| 62 | Gaze-evoked nystagmus (HP:0000640) | 2.25087812 |
| 63 | Urinary urgency (HP:0000012) | 2.23531463 |
| 64 | Clumsiness (HP:0002312) | 2.22656746 |
| 65 | Infertility (HP:0000789) | 2.22573652 |
| 66 | Peritonitis (HP:0002586) | 2.22433193 |
| 67 | Dialeptic seizures (HP:0011146) | 2.21194684 |
| 68 | Epidermoid cyst (HP:0200040) | 2.20486277 |
| 69 | Visual hallucinations (HP:0002367) | 2.19365306 |
| 70 | Decreased motor nerve conduction velocity (HP:0003431) | 2.17325221 |
| 71 | Increased IgE level (HP:0003212) | 2.17322384 |
| 72 | Absence seizures (HP:0002121) | 2.16617538 |
| 73 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.15445973 |
| 74 | Aplasia of the phalanges of the hand (HP:0009802) | 2.15445973 |
| 75 | Aplasia involving bones of the extremities (HP:0009825) | 2.15445973 |
| 76 | Abnormal ciliary motility (HP:0012262) | 2.13278896 |
| 77 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.13064224 |
| 78 | Abnormality of saccadic eye movements (HP:0000570) | 2.11904940 |
| 79 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.11507535 |
| 80 | Cubitus valgus (HP:0002967) | 2.10768805 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 2.10684490 |
| 82 | Hemiparesis (HP:0001269) | 2.08528958 |
| 83 | Apathy (HP:0000741) | 2.08507851 |
| 84 | Truncal ataxia (HP:0002078) | 2.08139316 |
| 85 | Mucopolysacchariduria (HP:0008155) | 2.07437340 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07437340 |
| 87 | Rhinitis (HP:0012384) | 2.06029976 |
| 88 | Protrusio acetabuli (HP:0003179) | 2.05505575 |
| 89 | Drooling (HP:0002307) | 2.05220914 |
| 90 | Excessive salivation (HP:0003781) | 2.05220914 |
| 91 | Peripheral demyelination (HP:0011096) | 2.04608698 |
| 92 | Hypoplasia of the iris (HP:0007676) | 2.03409893 |
| 93 | Myositis (HP:0100614) | 2.03202431 |
| 94 | Spondylolisthesis (HP:0003302) | 2.01961106 |
| 95 | Slow saccadic eye movements (HP:0000514) | 2.01890419 |
| 96 | Recurrent bacterial skin infections (HP:0005406) | 2.00198338 |
| 97 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99635722 |
| 98 | Atrophic scars (HP:0001075) | 1.99580758 |
| 99 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99282615 |
| 100 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99282615 |
| 101 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99282615 |
| 102 | Mitral stenosis (HP:0001718) | 1.98681497 |
| 103 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.98638890 |
| 104 | Akinesia (HP:0002304) | 1.98118701 |
| 105 | Abnormality of macrophages (HP:0004311) | 1.97606200 |
| 106 | Genetic anticipation (HP:0003743) | 1.96720870 |
| 107 | Hammertoe (HP:0001765) | 1.96237039 |
| 108 | Aortic aneurysm (HP:0004942) | 1.96055067 |
| 109 | Inappropriate behavior (HP:0000719) | 1.94489060 |
| 110 | Torticollis (HP:0000473) | 1.94150488 |
| 111 | Diminished motivation (HP:0000745) | 1.93865983 |
| 112 | Parakeratosis (HP:0001036) | 1.93675339 |
| 113 | Neonatal short-limb short stature (HP:0008921) | 1.93216113 |
| 114 | Febrile seizures (HP:0002373) | 1.92455561 |
| 115 | Loss of speech (HP:0002371) | 1.91998928 |
| 116 | Abnormal eating behavior (HP:0100738) | 1.91610914 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.91393254 |
| 118 | Vertebral arch anomaly (HP:0008438) | 1.91225680 |
| 119 | Cerebral hemorrhage (HP:0001342) | 1.90789697 |
| 120 | Abnormal gallbladder physiology (HP:0012438) | 1.90479015 |
| 121 | Cholecystitis (HP:0001082) | 1.90479015 |
| 122 | Amyloidosis (HP:0011034) | 1.89105680 |
| 123 | Distal sensory impairment (HP:0002936) | 1.89060855 |
| 124 | Clonus (HP:0002169) | 1.88917651 |
| 125 | Exercise-induced myalgia (HP:0003738) | 1.88621225 |
| 126 | Thick nail (HP:0001805) | 1.84434540 |
| 127 | Premature rupture of membranes (HP:0001788) | 1.84319139 |
| 128 | Broad-based gait (HP:0002136) | 1.84104570 |
| 129 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.83651057 |
| 130 | Absent frontal sinuses (HP:0002688) | 1.83076460 |
| 131 | Blue irides (HP:0000635) | 1.82823732 |
| 132 | Aortic dissection (HP:0002647) | 1.82652566 |
| 133 | Keratoconjunctivitis sicca (HP:0001097) | 1.81323382 |
| 134 | Increased CSF protein (HP:0002922) | 1.81310655 |
| 135 | Neuroendocrine neoplasm (HP:0100634) | 1.81300306 |
| 136 | Difficulty running (HP:0009046) | 1.79490478 |
| 137 | Abnormality of vision evoked potentials (HP:0000649) | 1.79430253 |
| 138 | Impaired social interactions (HP:0000735) | 1.79393968 |
| 139 | Abnormal social behavior (HP:0012433) | 1.79393968 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79222979 |
| 141 | Osteolytic defects of the hand bones (HP:0009699) | 1.79222979 |
| 142 | Status epilepticus (HP:0002133) | 1.78715080 |
| 143 | Foot dorsiflexor weakness (HP:0009027) | 1.78221852 |
| 144 | Wormian bones (HP:0002645) | 1.78030564 |
| 145 | Steppage gait (HP:0003376) | 1.77154109 |
| 146 | Generalized hypopigmentation of hair (HP:0011358) | 1.76976918 |
| 147 | Axonal loss (HP:0003447) | 1.75617352 |
| 148 | Thoracolumbar scoliosis (HP:0002944) | 1.75601696 |
| 149 | Abnormality of the axillary hair (HP:0100134) | 1.74305635 |
| 150 | Abnormality of secondary sexual hair (HP:0009888) | 1.74305635 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.73344282 |
| 152 | Diplopia (HP:0000651) | 1.73279819 |
| 153 | Abnormality of binocular vision (HP:0011514) | 1.73279819 |
| 154 | Postural tremor (HP:0002174) | 1.72887888 |
| 155 | Abnormality of the lower motor neuron (HP:0002366) | 1.72814605 |
| 156 | Overgrowth (HP:0001548) | 1.71802140 |
| 157 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.71409487 |
| 158 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71374842 |
| 159 | Papilledema (HP:0001085) | 1.71337461 |
| 160 | Ventricular fibrillation (HP:0001663) | 1.69449158 |
| 161 | Cerebral aneurysm (HP:0004944) | 1.67277355 |
| 162 | Papillary thyroid carcinoma (HP:0002895) | 1.67135430 |
| 163 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65713982 |
| 164 | Gangrene (HP:0100758) | 1.65690255 |
| 165 | Interstitial pulmonary disease (HP:0006530) | 1.65427832 |
| 166 | Hypercortisolism (HP:0001578) | 1.64435030 |
| 167 | Rapidly progressive (HP:0003678) | 1.64269056 |
| 168 | Hemiplegia (HP:0002301) | 1.64049582 |
| 169 | Keratoconjunctivitis (HP:0001096) | 1.63123580 |
| 170 | Ocular albinism (HP:0001107) | 1.63069965 |
| 171 | Recurrent abscess formation (HP:0002722) | 1.60696481 |
| 172 | Curly hair (HP:0002212) | 1.60577619 |
| 173 | Cranial hyperostosis (HP:0004437) | 1.60276507 |
| 174 | Obstructive sleep apnea (HP:0002870) | 1.58613783 |
| 175 | Abnormality of the frontal sinuses (HP:0002687) | 1.58174509 |
| 176 | Genu recurvatum (HP:0002816) | 1.56841921 |
| 177 | Dilatation of the ascending aorta (HP:0005111) | 1.54807801 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.61830276 |
| 2 | MARK1 | 2.67646290 |
| 3 | MAP3K9 | 2.57430122 |
| 4 | PDK3 | 2.44914383 |
| 5 | PDK4 | 2.44914383 |
| 6 | RIPK1 | 2.29200485 |
| 7 | OXSR1 | 2.28839483 |
| 8 | MOS | 2.22500249 |
| 9 | PRKD3 | 2.19100768 |
| 10 | PNCK | 2.17450425 |
| 11 | NTRK3 | 2.16459646 |
| 12 | EPHA4 | 2.06294361 |
| 13 | DDR2 | 2.05601096 |
| 14 | NTRK1 | 2.00213021 |
| 15 | ICK | 1.98406877 |
| 16 | PAK6 | 1.89879088 |
| 17 | WNK4 | 1.86633208 |
| 18 | MAP3K4 | 1.84118478 |
| 19 | WNK1 | 1.79013127 |
| 20 | PDK2 | 1.75732894 |
| 21 | STK24 | 1.74590835 |
| 22 | PKN1 | 1.66532993 |
| 23 | EPHB1 | 1.62622993 |
| 24 | NTRK2 | 1.61401772 |
| 25 | MAP2K4 | 1.59117687 |
| 26 | CASK | 1.58458715 |
| 27 | MAP3K14 | 1.57178327 |
| 28 | FGFR2 | 1.56526758 |
| 29 | MINK1 | 1.55959353 |
| 30 | CAMK1G | 1.55342628 |
| 31 | MAP3K3 | 1.50039487 |
| 32 | TYRO3 | 1.48143617 |
| 33 | BLK | 1.47779423 |
| 34 | MAP3K2 | 1.43393926 |
| 35 | KSR2 | 1.43266807 |
| 36 | MAP3K13 | 1.39461727 |
| 37 | PHKG2 | 1.38919029 |
| 38 | PHKG1 | 1.38919029 |
| 39 | DAPK2 | 1.38472447 |
| 40 | JAK1 | 1.36016537 |
| 41 | IRAK3 | 1.33596856 |
| 42 | NEK9 | 1.32964592 |
| 43 | PDGFRA | 1.32116164 |
| 44 | MAPK7 | 1.28524190 |
| 45 | BMPR2 | 1.27798451 |
| 46 | MAP2K7 | 1.25158806 |
| 47 | SGK223 | 1.24179422 |
| 48 | SGK494 | 1.24179422 |
| 49 | TGFBR2 | 1.22014636 |
| 50 | STK38 | 1.19426684 |
| 51 | IRAK4 | 1.18569973 |
| 52 | RIPK4 | 1.16072860 |
| 53 | CDK5 | 1.15735539 |
| 54 | PDGFRB | 1.13889530 |
| 55 | MAP3K6 | 1.12536109 |
| 56 | PAK3 | 1.11188813 |
| 57 | BCR | 1.07559905 |
| 58 | PTK2B | 1.07195808 |
| 59 | PIK3CG | 1.06868907 |
| 60 | PDPK1 | 1.04461619 |
| 61 | IKBKE | 1.03498037 |
| 62 | MAPKAPK5 | 1.02955957 |
| 63 | TBK1 | 1.02922029 |
| 64 | PDK1 | 1.00215438 |
| 65 | STK11 | 0.99400839 |
| 66 | TESK1 | 0.98411023 |
| 67 | CSNK1G2 | 0.98299709 |
| 68 | CSK | 0.96261044 |
| 69 | TNIK | 0.95410571 |
| 70 | GRK5 | 0.91359670 |
| 71 | CAMKK1 | 0.91029382 |
| 72 | UHMK1 | 0.90802939 |
| 73 | LMTK2 | 0.90216053 |
| 74 | CAMK2A | 0.88453292 |
| 75 | MARK3 | 0.87335698 |
| 76 | MARK2 | 0.87200015 |
| 77 | EPHA3 | 0.85464110 |
| 78 | FGFR3 | 0.84406331 |
| 79 | SIK2 | 0.83361557 |
| 80 | JAK2 | 0.83199081 |
| 81 | TYK2 | 0.82991033 |
| 82 | DMPK | 0.82945659 |
| 83 | LIMK1 | 0.81357493 |
| 84 | ERBB4 | 0.81153419 |
| 85 | TAOK2 | 0.80515983 |
| 86 | NEK6 | 0.80313042 |
| 87 | PRPF4B | 0.80262301 |
| 88 | PRKCG | 0.78499128 |
| 89 | RPS6KA2 | 0.76980098 |
| 90 | CAMK2B | 0.76376486 |
| 91 | RET | 0.76001897 |
| 92 | CSNK1A1L | 0.73880933 |
| 93 | IRAK2 | 0.73311188 |
| 94 | CDK19 | 0.73056563 |
| 95 | FGR | 0.72703802 |
| 96 | MAP3K5 | 0.69967067 |
| 97 | MAP2K3 | 0.69410350 |
| 98 | CAMK2D | 0.68480547 |
| 99 | MET | 0.68012877 |
| 100 | TRPM7 | 0.67451175 |
| 101 | IRAK1 | 0.66962517 |
| 102 | LATS1 | 0.66752566 |
| 103 | PINK1 | 0.66739918 |
| 104 | FES | 0.65806625 |
| 105 | CAMK2G | 0.65198751 |
| 106 | CAMK1D | 0.63434142 |
| 107 | MAPK13 | 0.62175960 |
| 108 | CDC42BPA | 0.61363018 |
| 109 | PRKCH | 0.61184790 |
| 110 | CSNK1G3 | 0.61141307 |
| 111 | CHUK | 0.61046555 |
| 112 | SGK1 | 0.60593332 |
| 113 | YES1 | 0.59743143 |
| 114 | PLK2 | 0.58046962 |
| 115 | DYRK1B | 0.57897666 |
| 116 | ZAP70 | 0.57793463 |
| 117 | CDK14 | 0.57611779 |
| 118 | ERN1 | 0.57573056 |
| 119 | HIPK2 | 0.57288515 |
| 120 | PRKCE | 0.57132456 |
| 121 | CDK12 | 0.56783712 |
| 122 | IKBKB | 0.56241538 |
| 123 | LATS2 | 0.56142866 |
| 124 | TAOK1 | 0.55244583 |
| 125 | BRD4 | 0.54846435 |
| 126 | SGK3 | 0.53901479 |
| 127 | PRKCZ | 0.53637884 |
| 128 | FER | 0.52593313 |
| 129 | MAPK12 | 0.52330997 |
| 130 | RAF1 | 0.50642760 |
| 131 | SGK2 | 0.50531100 |
| 132 | TTN | 0.50075688 |
| 133 | CDK15 | 0.49711714 |
| 134 | ARAF | 0.49207606 |
| 135 | ROCK2 | 0.49065203 |
| 136 | MAP3K1 | 0.48605793 |
| 137 | MAPK15 | 0.48573773 |
| 138 | FYN | 0.47545171 |
| 139 | KIT | 0.47504078 |
| 140 | CDK18 | 0.47271236 |
| 141 | PRKD1 | 0.46990418 |
| 142 | KSR1 | 0.46645738 |
| 143 | DYRK1A | 0.45943637 |
| 144 | CAMK1 | 0.45712660 |
| 145 | PRKG1 | 0.45538723 |
| 146 | SIK1 | 0.44895617 |
| 147 | CAMKK2 | 0.44576672 |
| 148 | GRK7 | 0.43287262 |
| 149 | MAPK4 | 0.42460475 |
| 150 | AKT3 | 0.41797660 |
| 151 | MAPK10 | 0.41723920 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02346161 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75062407 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.74741215 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.72384952 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.72156311 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.61924664 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60816045 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.58934582 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.55970582 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.50810683 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48375639 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.47349112 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47323059 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43844803 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.42225439 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.41914414 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39218232 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38495916 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.37532301 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.31852839 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30905142 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.30001677 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.29761172 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.28258545 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28189705 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.27520034 |
| 27 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.27012703 |
| 28 | Morphine addiction_Homo sapiens_hsa05032 | 1.26985237 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26057731 |
| 30 | Amoebiasis_Homo sapiens_hsa05146 | 1.25783544 |
| 31 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.23644919 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23587648 |
| 33 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21972701 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21004061 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17553653 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.16855518 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.16177424 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.14746438 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.14548595 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.14162300 |
| 41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13823361 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13594909 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13088788 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.12524671 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12396200 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.11431163 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09335013 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09198367 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07635099 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 1.05127468 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04224652 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.03121407 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 1.02667602 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02230528 |
| 55 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01886464 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 1.01829366 |
| 57 | * Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.00946467 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.99779043 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98737044 |
| 60 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98707607 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98560997 |
| 62 | Long-term depression_Homo sapiens_hsa04730 | 0.96918870 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96447570 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96211698 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95959964 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94279266 |
| 67 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93066887 |
| 68 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92549565 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91997663 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.91931797 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91260207 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.91018815 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.90983504 |
| 74 | Platelet activation_Homo sapiens_hsa04611 | 0.89112879 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.88870392 |
| 76 | Focal adhesion_Homo sapiens_hsa04510 | 0.88567585 |
| 77 | Taste transduction_Homo sapiens_hsa04742 | 0.88423254 |
| 78 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88345199 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88007863 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87825013 |
| 81 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87031134 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85735075 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84932225 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.84909404 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.84716145 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84432329 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.84054649 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83890133 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83882006 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83464230 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83092268 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82914569 |
| 93 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82556243 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81877814 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81164950 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81032773 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80986712 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.79828300 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.78377542 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76562728 |
| 101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76081469 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75811966 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75405756 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.75355847 |
| 105 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.75157489 |
| 106 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75056669 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73405771 |
| 108 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72980983 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72718319 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72123721 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71282139 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.71170355 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.71110652 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.70903238 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70423641 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70383345 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70377527 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70363459 |
| 119 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70062367 |
| 120 | Hepatitis B_Homo sapiens_hsa05161 | 0.69999282 |
| 121 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69854799 |
| 122 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68821330 |
| 123 | Legionellosis_Homo sapiens_hsa05134 | 0.68606382 |
| 124 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67873344 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66551020 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66549924 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66520890 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65978652 |
| 129 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65954445 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64147457 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63915256 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.63739436 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63725745 |
| 134 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63042386 |
| 135 | Measles_Homo sapiens_hsa05162 | 0.62712722 |
| 136 | Gap junction_Homo sapiens_hsa04540 | 0.61910612 |
| 137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61713493 |
| 138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61700817 |
| 139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61247864 |
| 140 | Mineral absorption_Homo sapiens_hsa04978 | 0.61100513 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60958941 |
| 142 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.60880257 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60726861 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60671476 |
| 145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.60571328 |
| 146 | Peroxisome_Homo sapiens_hsa04146 | 0.59302550 |
| 147 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.58592816 |
| 148 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58214536 |
| 149 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57993544 |
| 150 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57734402 |
| 151 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57458248 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55046038 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.54983017 |
| 154 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53602453 |
| 155 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53186116 |
| 156 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53022572 |
| 157 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50577509 |
| 158 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49189676 |
| 159 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48582826 |
| 160 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48213588 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48108738 |

